Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers

Published date04 January 2021
Subject MatterFinal Rules,Anti-Kickback Statute,Medicaid,Value-Based Purchasing,FD&C Act,Medicaid Drug Rebate Program,Centers for Medicare & Medicaid Services (CMS)
AuthorDavid Farber,John Shakow,Elizabeth Lindquist,Preeya Pinto,Michael Dohmann
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT